2 or more items
receive a 5% discount !
Because of the corona pandemic and its effect on global logistic systems we are currently unable to ship directly to many non-EU countries. US and Canadian customers can place their orders with our California-based US partner, though. Customers in Australia / Asia - you can place your orders with our Australian partner.
Right now we are shipping to only a select number of non-EU countries, and for the time being, only registered shipping with tracking. So, no free shipping for the time being. You can see whether or not your region is included when checking out.
Transit times are unpredictable but almost guaranteed to be longer than usual, in general. We have no control over this.
This situation will last at least until the corona pandemic has been contained. In case you registered for our newsletter in the past: you will be notified when the situation changes. If not. check this page from time to time for updates.
Stay healthy !
The Oriveda Team
Maitake's therapeutic potential has been researched intensively since the late 1970s. It was the hype of the day during the 1990's, a reputation based on promising research results.
Our research section has several interesting publications, free to download.
Before you start using Google, read the other entry on this page: 'Why ORIVeDA's Grifolan ?' or, even better, read this extensive background article.
First of all, click here to see our authorized 'Supplement Facts' label.
And then use Google to look for additional details on Maitake's therapeutic potential - you will read about the 'D-Fraction®*', the 'MD-Fraction' and others.
The d-fraction is originally a term coined in the 1980s; it referred then to a purified -fractionated- beta-glucan, bonded with a protein; a so-called 'proteoglycan'. This particular fraction showed a lot of promise because of its anti-tumor potential.
Unfortunately, neither this product nor its successor, the md-fraction (a more pure version of the d-fraction, patented in 1997) is for sale in its undiluted pure form; the production costs are probably too high (it's a 200 : 1 extract) and the fractionating process is too complex for mass-production.
Although the manufacturers prefer to keep the details as vague as possible (marketing reasons), here are some -verifiable- facts:
Summarizing: Based on the existing facts we feel confident ORIVeDA Grifolan® is at least equal to, if not more potent than the best of the current commercially available Maitake products. Apart from that, the value for money is much better.*D-Fraction® and PD-Fraction® are trademarks of Mushroom Wisdom, Inc., NJ, USA. MaitakeGold 404® (MTG) is a trademark of The Tradeworks Group, VT, USA
Immunological effects of 39 mushroom supplements compared. [source]